Development of a low-seroprevalence, avß6 integrin-selective virotherapy based on human adenovirus type 10. (2022)

First Author: Bates EA
Attributed to:  MICA: Targeting the Wnt Receptor Frizzled-7 for the Treatment of Gastric Cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omto.2022.03.007

PubMed Identifier: 35399606

Publication URI: http://europepmc.org/abstract/MED/35399606

Type: Journal Article/Review

Volume: 25

Parent Publication: Molecular therapy oncolytics

ISSN: 2372-7705